Answers are grounded in this paper and cite their sources.
Purpose: This study evaluates the efficacy of a patient blood management (PBM) initiative in reducing unnecessary red blood cell (RBC) transfusions at a New York City community teaching hospital over eight years (2013–2020). Methods: A retrospective analysis of RBC transfusion data was performed, covering the period from 2013 to 2020. Findings: Post-PBM implementation, notable advancements were recorded annually. Mean pretransfusion hemoglobin (Hgb) levels decreased from 7.26 g/dL in 2013 to 6.68 g/dL in 2020. Annual RBC transfusion units decreased, with units transfused at Hgb ≥ 7 g/dL falling from 1210 (58.7%) in 2013 to 377 (20.0%) in 2020, a drop of 39%. Two-unit RBC orders at Hgb ≥ 7 g/dL declined from 65 in 2013 to 10 in 2020. Estimated cost savings from 2014 to 2020 totaled US Dollar (USD) 2.2 million. Conclusions: The PBM program significantly curtailed unnecessary RBC transfusions and optimized transfusion practices, demonstrating that resource-light, evidence-based strategies can yield substantial clinical and economic benefits.
No takes yet. Share an insight, caveat, or question.
Karpinos et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: